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This article describes a differential pulse voltammetric (DPV) method for the determination of diclofenac 
in pharmaceutical preparations and human serum. The proposed method was based on electro-oxidation 
of diclofenac at platinum electrode in 0.1 M TBAClO4/acetonitrile solution. The well-defined two 
oxidation peaks were observed at 0.87 and 1.27 V, respectively. Calibration curves that obtained by 
using current values measured for second peak were linear over the concentration range of 1.5-17.5 μg 
mL-1 and 2-20 μg mL-1 in supporting electrolyte and serum, respectively. Precision and accuracy were 
also checked in all media. Intra- and inter-day precision values for diclofenac were less than 3.87, and 
accuracy (relative error) was better than 4.12%. The method developed in this study is accurate, precise 
and can be easily applied to Diclomec, Dicloflam and Voltaren tablets as pharmaceutical preparation. In 
addition, the proposed technique was successfully applied to spiked human serum samples. No electro-
active interferences from the endogenous substances were found in human serum.
Uniterms: Diclofenac/determination. Differential pulse voltammetry/quantitative analysis. 
Pharmaceutical formulations/analysis. Human serum/analysis
Este artigo descreve um método de voltametria de pulso diferencial (VPD) para a determinação de 
diclofenaco em preparações farmacêuticas e em soro humano. O método proposto foi baseado em 
eletroxidação de diclofenaco no eléctrodo de platina em solução 0,1 M TBAClO4/acetonitrila. Dois picos 
de oxidação bem definidos foram observados em 0,87 e 1,27 V, respectivamente. As curvas de calibração 
obtidas utilizando-se valores de corrente medidos por segundo pico foram lineares no intervalo de 
concentração de 1,5-17,5 μg mL-1 e 2-20 μg mL-1 em eletrólito suporte e soro, respectivamente. Precisão 
e exatidão também foram verificadas em todos os meios. Valores de precisão intra- e inter-dia para o 
diclofenaco foram inferiores a 3.87 e a precisão (erro relativo) foi melhor do que 4,12%. O método 
desenvolvido neste estudo é exato, preciso e pode ser facilmente aplicado a Diclomec, Dicloflam e 
comprimidos Voltaren, como preparação farmacêutica. Além disso, a técnica proposta foi aplicada com 
sucesso em amostras de soro humano. Não se observaram interferências das substâncias endógenas no 
soro humano.
Unitermos: Diclofenaco/determinação. Voltametria de pulso diferencial/análise quantitativa. Formulações 
farmacêuticas/análise. Soro humano/análise.
INTRODUCTION
Diclofenac (Figure 1), [o-(2,6-dichloroanilino)
phenyl] acetate), is a non-steroidal anti-inflammatory 
drug (NSAID) with strong anti-pyretic, analgesic and anti-
inflammatory properties (Iliiescu, Baia, Miclaus, 2004).
It is widely used in clinical medicine for the treatment 
of inflammatory conditions such as rheumatoid arthritis, 
osteoarthritis and ankylosing spondylitis (Gostick et al., 
1990; Crowley et al., 1990). The efficacy of diclofenac 
equals that of many newer and established NSAIDs. As an 
analgesic, it has a fast onset and a long duration of action. 
Compared to other NSAIDs, diclofenac is well tolerated 
and rarely produces gastrointestinal ulcerations or other 
serious side effects. Thus, diclofenac can be considered as 
one of few non-steroidal anti-inflammatory drugs of first 
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choice used in the treatment of acute and chronic, painful 
and inflammatory conditions (Roskar, Kmetec, 2003).
To date, several methods for the determination 
of diclofenac have been reported. These include 
potentiometry (Shamsipur, Jalali, Ershad, 2005; Santini, 
Pezza, Pezza, 2006; Hassan et al., 2005), capillary zone 
electrophoresis (Jin, Zhang, 2000), high performance 
liquid chromatography (HPLC) (González, Yuln, Volonté, 
1999; Kasperek, 2008; Arcelloni et al., 2001), high-
performance liquid chromatography-mass spectrometry 
(HPLC-MS) (Abdel-Hamid, Novotny, Hamza, 1990), 
spectrophotometry (Botello, Perez-Caballero, 1995), 
spectrofluorometry (Arancibia, Boldrini, Escandar, 2000; 
Damiani et al., 1999; Carreira et al., 1995), thin layer 
chromatography (Sun, Fabre, 1994), gas chromatography 
(Siou, Pommier, Godbillon, 1991; Yilmaz, 2010), 
polarographic analysis (Xu, Chen, Song, 2004), 
spectrophotometry (De Souza, Tubino, 2005; Agatonovic-
Kustrin et al., 1997; Matin, Farajzadeh, Joyuban, 2005; 
Sastry, Prasad-Tipirneni, Suryanarayana, 1989; Sena et 
al., 2004) and electrochemistry methods (Blanco-Lopez et 
al., 2003; Goyal, Chatterjee, Agrawal, 2010; Manea et al., 
2010). In all electrochemical methods, modified electrodes 
were used due to the gradual passivation or contamination 
of unmodified solid working electrodes occurred during 
the diclofenac oxidation. The development of modified 
electrodes is certainly one of the most extensive areas 
of research in analytical chemistry. However, it should 
be emphasized that electrode modification is frequently 
considered tedious and laborious process that can limit 
the use of these types of electrodes in routine analysis. 
Carbon-paste electrodes, due to their ease of construction, 
renewability and compatibility with various types of 
modifiers, have been widely used as a suitable matrix 
for the preparation of modified electrodes. Further, they 
show rather low background current compared to solid 
graphite or noble metal electrodes (Valentini et al., 2003). 
In recent years, applications of carbon nanotube modified 
carbon paste electrodes have provided considerable 
improvements in the electrochemical behaviour of 
biologically important compounds (Antiochia et al., 2004; 
Norouzi et al., 2007). Metal nanowires such as dysprosium 
showed behaviour like carbon nanotubes. A carbon-
paste electrode containing 10% (w/w) of dysprosium 
nanowire/carbon paste electrode, in comparison with 
carbon-paste electrodes without nanowire, showed a 
very effective catalytic activity in the electrochemical 
oxidation of diclofenac. The reported methods were 
influenced by interference of endogenous substances and 
potential loss of drugs in the re-extraction procedure and 
involving lengthy, tedious and time-consuming plasma 
sample preparation and extraction processes requiring a 
sophisticated and expensive instrumentation.
The development of a new method capable of 
determining the drug amount in pharmaceutical dosage 
forms is important. Electro-analytical techniques have 
been used for the determination of a wide range of 
drug compounds with the advantages that there are, 
in most, instances no need for derivatization and that 
these techniques are less sensitive to matrix effects than 
other analytical techniques. Additionally, application 
of electrochemistry includes the determination of 
electrode mechanism. Redox properties of drugs can 
give insights into their metabolic fate or their in vivo 
redox processes or pharmacological activity (Kissenger, 
Heineman, 1996; Kauffmann, Vire, 1993; Ozkan, Uslu, 
Senturk, 2004). Despite the analytical importance of the 
electrochemical behaviour and oxidation mechanism 
of diclofenac, no report has been published on the 
voltammetric study of the electrochemical oxidation 
of diclofenac in non-aqueous media. Diclofenac is not 
soluble in water. It can be dissolved in water containing 
30% methanol. Methanol has a narrow potential range. 
Therefore, it was dissolved in acetonitrile which had wide 
potential range.
It is well known that the experimental and 
instrumental parameters directly affect the electrochemical 
process and voltammetric response of drugs. Consequently, 
it would be interesting to investigate the oxidation process 
of diclofenac in aprotic media. Therefore, the goal of 
this work was the development of new DPV method for 
the direct determination of diclofenac in pharmaceutical 
preparations and spiked human serum samples without 
any time-consuming extraction or evaporation steps 
prior to drug assay. This paper describes fully validated, 
simple, rapid, selective and sensitive procedures for 
the determination of diclofenac employing DPV at the 
platinum disc electrode. Besides, the proposed method 
FIGURE 1 - Chemical structure of sodium diclofenac.
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might be an alternative to the chromatographic methods 
in therapeutic drug monitoring.
MATERIAL AND METHODS
Chemicals and reagents
Diclofenac was obtained from Sigma (St. Louis, MO, 
USA). Acetonitrile (Fluka for HPLC analysis) was purified 
by drying with calcium hydride, followed by distillation 
from phosphorus pentoxide. Tetrabutylammonium 
perchlorate (TBAClO4) were purchased from Fluka 
and used as received without further purification. 
Diclomec, Dicloflam and Voltaren tablets were obtained 
from pharmacy (Erzurum, Turkey). Human serum 
was obtained from Yakutiye blood bank, Erzurum, 
Turkey.
Electrochemical instrumentation
Electrochemical experiments were performed on 
a Gamry Potentiostat Interface 1000 controlled with 
software PHE 200 and PV 220. All measurements were 
carried out in a single-compartment electrochemical cell 
with a standard three-electrode arrangement. A platinum 
disk with an area of 0.72 cm2 and a platinum wire were used 
as the working and the counter electrodes, respectively. 
The working electrode was successively polished with 
1.0, 0.3 and 0.05 µm alumina slurries (Buehler) on 
microcloth pads (Buehler). After each polishing, the 
electrode was washed with water and sonicated for 10 
min in acetonitrile. Then, it was immersed into a hot 
piranha solution (3:1, H2SO4, 30% H2O2) for 10 min, and 
rinsed copiously with water. All potentials were reported 
versus Ag/AgCl/KCl (3.0 M) reference electrode (BAS 
Model MF-2078) at room temperature. The electrolyte 
solutions were degassed with purified nitrogen for 10 
min before each experiment and bubbled with nitrogen 
during the experiment. Operating conditions for DPV were 
pulse amplitude 50 mV, pulse width 50 ms and scan rate 
20 mV s-1.
Preparation of the standard and quality control 
solutions
The stock standard solution of diclofenac was 
prepared in 0.1 M TBAClO4/acetonitrile to a concentration 
of 100 µg mL-1 and stored at 4 °C. Working standard 
solutions were prepared from the stock solution. A 
calibration graph was constructed in the range of 1.5, 2.5, 
5, 7.5, 10, 12.5, 15 and 17.5 µg mL-1 for diclofenac (n=6). 
For quality control (QC) samples containing concentration 
4, 8 and 16 µg mL-1 of diclofenac, the stock solution was 
diluted with 0.1 M TBAClO4/acetonitrile.
Procedure for pharmaceutical preparations
A total 10 tablets of diclofenac (Diclomec, Dicloflam 
and Voltaren) were accurately weighed and powdered. 
An amount of this powder corresponding to one tablet 
diclofenac content was weighed and accurately transferred 
into 100 mL calibrated flask and 50 mL of 0.1 M TBAClO4/
acetonitrile was added and then the flask was sonicated to 
10 min at room temperature. The flask was filled to volume 
with 0.1 M TBAClO4/acetonitrile. The resulting solutions 
in both cases were filtered through Whatman filter paper 
no 42 and suitably diluted to get final concentration within 
the limits of linearity for the respective proposed method. 
The drug content of diclofenac tablets was calculated from 
the current potential curve.
Recovery studies
To study the accuracy and reproducibility of the 
proposed technique, recovery experiments were carried 
out using the standard addition method. In order to know 
whether the excipients show any interference with the 
analysis, known amounts of pure diclofenac were added 
to the pre-analysed tablet formulation and the mixtures 
were analysed by the proposed method. After five repeated 
experiments, the recovery results were calculated using the 
calibration equation.
Analysis of spiked serum samples
Drug-free human blood, obtained from healthy 
volunteers (after obtaining their written consent), was 
centrifuged (5000 rpm) for 30 min at room temperature 
and separated serum samples were stored frozen until 
assay. An aliquot volume of serum sample was fortified 
with diclofenac dissolved in acetonitrile to achieve final 
concentration of 100 µg mL-1. Acetonitrile removes serum 
proteins more effectively, as the addition of 1.0 mL volume 
of serum is sufficient to remove the proteins. After vortexing 
for 30 s, the mixture was then centrifuged for 5 min at 
5000 rpm for getting rid of serum protein residues and the 
supernatant was taken carefully. Appropriate volumes of 
this supernatant were transferred into the volumetric flask. 
The concentration of diclofenac was varied in the range of 
2-20 µg mL-1 in human serum samples. Quantifications were 
performed by means of calibration curve method from the 
related calibration equation.
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RESULTS AND DISCUSSION
Voltammetric behaviour of diclofenac
The electrochemical behaviour of diclofenac 
was investigated at the Pt disc electrode in anhydrous 
acetonitrile solution containing 0.1 M TBAClO4 as the 
supporting electrolyte by using cyclic voltammetry 
(CV). Figure 2 shows a typical cyclic voltammogram of 
20 μg mL-1 diclofenac recorded under these conditions 
for the scan rate of 0.2 V s-1. In the anodic sweep, two 
oxidation peaks are seen at about the potentials of 0.87 
and 1.27 V, respectively.
In order to gain a deeper insight into the voltammetric 
waves, the effect of scan rate on the anodic peak currents 
(I) and peak potentials (E) was studied in the range of 
0.01-1 V s-1 of the potential scan rates in acetonitrile 
solution containing 20 μg mL-1 concentration of diclofenac 
(Figure 3).
The representative linear sweep voltammograms 
obtained at Pt electrode for 20 μg mL-1 diclofenac as a 
function of the scan rate are presented in Figure 4. Scan rate 
dependency experiments show that the peak currents vary 
linearly with the scan rate (ν) (Figures 4a,b), which points 
out the adsorption-controlled process. However, the plots of 
logarithm of peak currents versus logarithm of scan rates for 
20 μg mL-1 concentration of diclofenac display straight lines 
with 0.497 slope (Figure 4c), which are close to theoretical 
value of 0.5 expected for an ideal diffusion-controlled 
electrode process (Laviron, Roullier, Degrand, 1980).
Log I-log ν curve is more eligible for this aim, 
therefore, a diffusional process for peak should be 
considered. These results suggest that the redox species 
are diffusing freely from solution and not precipitating 
onto the electrode surface. The reason for this behaviour 
may be due to the solubility of the intermediate species in 
acetonitrile or poor adherence of products on the electrode 
surface.
The oxidation peak potential (E) for the peaks shifts 
toward more positive values with increasing scan rate. The 
relationship between the peak potential and scan rate is 
described by the following equation,
E = E0’ + RT/[(1 – )naF][0.78 + ln(D1/2ks-1) –  
0.5 lnRT/[(1 – )naF]] + RT/[(1 – )naF]/2 lnv
and from the variation of peak potential with scan rate 
αna can be determined, where α is the transfer coefficient 
and na is the number of electrons transferred in the rate 
determining step. According to this equation, the plots of 
the peak potentials versus ln ν for the oxidation peak show 
linear relationship. The slope indicates the value of αna is 
0.38 for peak. On the basis of above results, na is 1 then 
the value of α is calculated as 0.38, which is reasonable 
for most irreversible electrode processes. Based on 
above discussions, the oxidation process of diclofenac is 
controlled by the diffusion step and one electron and one 
proton are involved in the reaction.
Analytical applications and validation of the 
proposed method
In order to develop a voltammetric procedure for the 
FIGURE 2 - Cyclic voltammogram for the oxidation of 
20 μg mL-1 diclofenac in acetonitrile containing 0.1 M TBAClO4 
at Pt disk electrode, scan rate: 0.2 V s-1.
FIGURE 3 - Linear sweep voltammograms for the oxidation of 
20 μg mL-1 diclofenac in acetonitrile containing 0.1 M TBAClO4 
as a function of scan rate.
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FIGURE 4 - A, B, C: Dependence of peak current on the scan rate (20 μg mL-1).
determination of drug, we selected the DPV technique, 
since the peaks were sharper and better defined at lower 
concentration of diclofenac than those obtained by cyclic 
and linear sweep voltammetry with a lower background 
current, resulting in improved resolution. DPV is an 
effective and rapid electro-analytical technique with well-
established advantages, including good discrimination 
against background currents and low detection limits 
(Wang, 1996; Kissenger,Heineman, 1996).
Calibration graphs from the standard solution of 
diclofenac according to the procedures described above 
were constructed by using DPV. A linear relation in the 
concentration range between 1.5-17.5 μg mL-1 was found, 
indicating that the response was diffusion controlled in 
this range (Figure 5).
Above this concentration (17.5 μg mL-1), a loss of 
linearity was probable due to the adsorption of diclofenac 
on the electrode surface. The characteristics of the 
calibration plots are summarized in Table I.
The precision of the DPV method was determined 
by repeatability (intra-day) and intermediate precision 
(inter-day). Repeatability was evaluated by analysing QC 
samples six times per day, at three different concentrations 
which were QC samples. The intermediate precision 
was evaluated by analysing the same samples once daily 
for two days. The RSD of the predicted concentrations 
from the regression equation was taken as precision. 
The accuracy of this analytic method was assessed as the 
percentage relative error. For all concentrations studied, 
intra- and inter-day relative standard deviation values 
were ≤3.87% and for all concentrations of diclofenac the 
relative errors were ≤4.12%.
The limit of detection (LOD) and the limit of 
quantification (LOQ) were calculated on the peak current 
using the following equation:
LOD = 3 s/m; LOQ = 10 s/m
FIGURE 5 - DPV voltammograms obtained for determination 
in supporting electrolyte (blank, 1.5, 2.5, 5, 7.5, 10, 12.5, 15 
and 17.5 µg mL-1).
where s is the standard deviation of the peak currents 
(three runs) and m is the slope of the calibration curve. 
The LOD and LOQ values were also shown in Table I. 
Repeating five experiments on 15 μg mL-1 diclofenac for 
DPV technique tested the repeatability and reproducibility 
of peak potential and peak currents. The results were 
shown also in Table I. Repetition of the sample analysis 
after 72 h period did not show any significant change in 
the results of the analyses.
Determination of diclofenac in tablets
On the basis of above results, DPV method was 
applied for the direct determination of diclofenac in 
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pharmaceutical preparations, using the related calibration 
straight lines without any sample extraction or filtration 
and after adequate dilutions. The results show that the 
proposed method was successfully applied for the assay of 
diclofenac in its pharmaceutical dosage forms (Table II). 
The accuracy of the method was determined by its 
recovery during spiked experiments. Recovery studies 
were carried out after the addition of known amounts 
of the pure drug to various pre-analysed formulation of 
diclofenac. According to the results, excipients presented 
in tablet do not interfere with the analysis (Table II).
There is no official method in any pharmacopoeias 
(e.g. USP, BP or EP) or literature method related to 
pharmaceutical dosage forms of diclofenac. To prove the 
absence of interferences by excipients, recovery studies 
were carried out. The results demonstrate the validity of 
the proposed method for the determination of diclofenac in 
tablets. These results reveal that both methods had adequate 
precision and accuracy and consequently can be applied to 
the determination of diclofenac in pharmaceuticals without 
any interference from the excipients.
Birajdar, Meyyanathan and Suresh (2010) developed 




Measured potential (V) 1.34 1.31






LOD (μg mL-1) 0.30 0.60
LOQ (μg mL-1) 0.90 1.80
Precision (RSD%) 2.96 3.87
Accuracy (% relative error) 3.46 4.12
Repeatability of peak current (RSD%)a 1.38 2.67
Repeatability of peak potential (RSD%) 1.94 2.46
Reproducibility of peak current (RSD%) 2.96 3.24
Reproducibility of peak potential (RSD%) 0.69 1.24
RSD: Relative standard deviation, aAverage of six replicate determinations, Sa: Standard deviation of intercept of regression line, 
Sb: Standard deviation of regression line slope, R: Correlation coefficient, LOD: Limit of detection, LOQ: Limit of quantification
TABLE II - Recovery of the diclofenac in pharmaceutical preparations
Diclomec Dicloflam Voltaren
Labelled claim (mg) 100 50 75
Amount found (mg)a 99.4 50.2 75.4
RSD% 2.43 1.84 2.73
Bias% -0.60 0.40 0.53
Added (μg mL-1) 10 10 10
Found (μg mL-1) 9.94 10.04 10.09
Recovery% 99.4 100.4 100.9
RSD% of recovery 2.52 1.92 2.32
a Each value is the mean of five experiments
Differential pulse voltammetric determination of diclofenac in pharmaceutical preparations and human serum 291




(Mean ± SDa) % Recovery % RSD
b
2 1.86 ± 0.051 93.0 2.74
5 4.83 ± 0.219 96.6 4.53
7.5 7.45 ± 0.499 99.3 6.69
10 9.82 ± 0.785 98.2 7.99
12.5 12.32 ± 1.08 98.6 8.77
15 14.82 ± 1.29 98.8 8.70
17.5 18.04 ± 1.67 103.7 9.25
20 20.2 ± 1.65 101.0 8.17
SDa: Standard deviation of six replicate determinations, 
RSD: Relative standard deviation, bAverage of six replicate 
determinations
a reverse phase HPLC method for the simultaneous 
determination of rabeprazole and diclofenac in tablet. The 
method was based on HPLC separation of both drugs in 
reverse phase mode using Phenomenox C18 column with 
Waters HPLC system by using mobile phase composition 
of acetonitrile and 50 mM ammonium acetate buffer 
(pH 3.6) (60:40 v/v) at flow rate 1mL min-1. Detection 
wavelength used at 254 nm. Linearity was obtained in the 
concentration range of 1.0-3.2 µg mL-1 for rabeprazole and 
6.0-16.0 µg mL-1 diclofenac.
Sastry, Prasad-Tipirneni and Suryanarayana 
(1989) described a spectrophotometric method for 
the determination of diclofenac sodium in bulk 
samples and pharmaceutical  preparat ions with 
p-N,N-dimethylphenylenediamine as solvent and 
maximum absorbance at 670 nm. The reaction is sensitive 
enough to permit the determination of 2.0-24 µg mL-1.
Agrawal Shivramchandra (1991) described two 
methods for the determination of diclofenac. In the first 
method diclofenac reduces iron(III) to iron(II) having 
a maximum absorbance at 520 nm. The reaction obeys 
Beer’s law for the concentrations of 10-80 µg mL-1. In 
the second method, diclofenac is treated with methylene 
blue in the presence of phosphate buffer (pH 6.8) and the 
complex is extracted with chloroform. The complex has a 
maximum absorbance at 640 nm and linearity was in the 
range 5-40 µg mL-1.
Thongchai  et  al .  (2006) developed a high 
performance thin layer chromatographic method for the 
determination of diclofenac sodium in pharmaceutical 
formulations. The drug was extracted from the sample then 
various aliquots of this solution were spotted automatically 
by means of Camag Linomat IV on a silica gel 60 F254 
aluminium plate, using a mixture of toluene: ethyl acetate: 
glacial acetic acid (60:40:1, v/v/v) as mobile phase. The 
spot areas were quantified by densitometry at 282 nm. 
Linear calibration curve was obtained over the range 
5-80 µg mL-1.
For DPV measurements, calibration curve was 
linear over the concentration range of 1.5-17.5 μg mL-1 for 
diclofenac, which is as good as or superior to that reported 
in other papers (Birajdar, Meyyanathan, Suresh, 2010; 
Sastry, Prasad-Tipirneni, Suryanarayana, 1989; Agrawal 
et al., 1991; Thongchai et al., 2006).
Determination of diclofenac in human serum 
samples
The optimized procedure was successfully applied 
for the determination of diclofenac in protein-free spiked 
human serum samples. Acetonitrile and methanol were 
tried as the serum precipitating agents. The best results 
were obtained with acetonitrile. Hence, acetonitrile was 
used for the following studies. The measurements of 
diclofenac in serum samples were performed as described 
in the analysis of spiked serum samples section. For the 
applicability of the proposed method to the human serum, 
the calibration equation was obtained in spiked human 
serum. Calibration equation parameters and validation 
data are shown in Table I. Obtained recovery results of 
spike human serum samples are given in Table III.
Using the proposed DPV technique, no sample 
pre-treatment was required other than precipitation and 
dilution steps. The recovery results of diclofenac (Table 
III) in serum samples were calculated from the related 
linear regression equations, which are given in Table 
I. Good recoveries of diclofenac were achieved from 
this type of matrix. Analysis of serum samples by DPV 
involved only protein precipitation and centrifugation, 
no time-consuming extraction and evaporation steps 
are required. In this study, the serum proteins and 
endogenous substances in serum samples are precipitated 
by the addition of acetonitrile, which is centrifuged at 
5000 rpm, and the supernatant was taken and diluted with 
the supporting electrolyte and directly analysed. Typical 
DPV curve of diclofenac examined in serum samples are 
shown in Figure 6.
As can be seen in Figure 6, no oxidation compounds 
and no extra noise peaks present in biological material 
peak occurred in the potential range where the analytical 
peak appeared.
Stability of serum samples kept in refrigerator 
(+4 °C) was tested by making five consecutive analyses of 
the sample over a period of approximately 5 h. There were 
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no significant changes in the peak currents and potentials 
between the first and last measurements.
CONCLUSIONS
In this work, a new DPV technique has been 
developed for the determination of diclofenac in 
pharmaceutical preparations and human serum samples. 
The results obtained show that the above-described 
methods are useful not only for diclofenac determination 
in conventional electrolytes, but also in more complex 
matrices such as dosage forms and human serum samples. 
The principal advantages of DPV technique over other 
techniques are that they may be applied directly to the 
analysis of pharmaceutical dosage forms and biological 
samples without the need for separation or complex 
sample preparation, since there was no interference from 
the excipients and endogenous substances. The method is 
rapid, requiring less than 5 min to run sample.
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